Stocks
Eli Lilly and Company (LLY) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 29.6% | 31.1% | 30.9% | 33.1% | 36.5% | 43.2% | ||
| Changes by years, y/y, % | -15pp | +2pp | 0pp | +2pp | +3pp | -4.0% | |||
Eli Lilly and Company. EBITDA margin, %
Eli Lilly and Company. EBITDA margin, changes, pp
Eli Lilly and Company (LLY) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | 24.5% | 27.9% | 67.4% | 38.5% | 36.6% | 43.2% | |
| Changes by years, y/y, % | -11pp | -4pp | +33pp | +6pp | +12pp | |||
| Changes by quarters, q/q, % | -8pp | +3pp | +39pp | -29pp | -2pp | |||
